江西成琚药业有限公司
江西成琚药业有限公司
About Us
Contact Supplier
Hexamethylphosphoramide
Chemicals/Heterocyclic Compounds/Organic IntermediatesNegotiable
Send Inquiry
Creatine Monohydrate
Chemicals/Other Organic Raw Materials/Other Organic Raw MaterialsNegotiable
Send Inquiry
fludrocortisone acetate
Chemicals/Pharmaceutical & Biochemical/Hormones & Related DrugsNegotiable
Send Inquiry
4-Androstenedione
Chemicals/Pharmaceutical & Biochemical/APIs (Active Pharmaceutical Ingredients)Negotiable
Send Inquiry
Hydrocortisone
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
Hydrocortisone acetate
Chemicals/Pharmaceutical & Biochemical/Hormones & Related DrugsNegotiable
Send Inquiry
Cortisone acetate
Chemicals/Pharmaceutical & Biochemical/Hormones & Related DrugsNegotiable
Send Inquiry
Marbofloxacin
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
9β,11β-epoxy-17,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione
Chemicals/Pharmaceutical & Biochemical/APIs (Active Pharmaceutical Ingredients)Negotiable
Send Inquiry
Chengju Pharmaceutical was established in June 2013;
In September 2019, the company was recognized as a "National High-Tech Enterprise";
In February 2020, it undertook the production task of disinfectants for combating the COVID-19 pandemic in Shangrao City, cumulatively donating over 50 tons to Hubei Province for pandemic relief.
In September 2021, led by Chairman Yu Chengwang with follow-up investment from Xianju Pharmaceutical, Chengju Pharmaceutical underwent a capital increase and share expansion. By introducing strategic resources such as product varieties, technology, market, and talent from strategic investors, Chengju Pharmaceutical accelerates its transformation and upgrading to become a trusted CMO win-win partner!
